Physician profile
Yusuke Hashimoto
NPI 1902477565
$3,745.21
in general payments reported to CMS, 2019-2025
7 companies · $2,687 in 2025
The $2,687 reported for 2025 was more than what 85% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.17 · 2022: $802 · 2023: $135 · 2024: $50.29 · 2025: $2,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,006 · Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,005.76 |
| Food and Beverage | $865.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,445.49 | 2025 | Axios, Overstitch Endoscopic Suturing System |
| Olympus America INC. | $748.48 | 2021-2025 | Evis Exera III Video System Center, Single Use Electrosurgical Knife Kd-655, Gastrointestinal Videoscope |
| Abbvie INC. | $190.87 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $136.38 | 2022 | |
| Janssen Scientific Affairs, LLC | $111.35 | 2022 | |
| Lumendi LLC | $97.18 | 2022 | |
| Apollo Endosurgery US INC | $15.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yusuke Hashimoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.